Sun Pharm Drug Patent Portfolio

Sun Pharm's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sun Pharm News

With the patent expiration of semaglutide, a surge in weight-loss opportunities emerges. Pharmaceutical companies make significant investments while a legal dispute remains unresolved.

07 Mar, 2026

Forecast and Size of the Generic Drug Market in the United States by 2025 | Trader - Vocal Media

11 Feb, 2026

Sun Pharma receives approval to market generic Wegovy in India - The HinduBusinessLine

23 Jan, 2026

Sun Pharma obtains regulatory clearance to market generic Wegovy in India | Company News

23 Jan, 2026

See More